Castle Biosciences
CSTL
CSTL
135 hedge funds and large institutions have $391M invested in Castle Biosciences in 2023 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 52 increasing their positions, 41 reducing their positions, and 16 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more capital invested
Capital invested by funds: $ → $
4% more funds holding
Funds holding: 130 → 135 (+5)
0.29% more ownership
Funds ownership: 86.07% → 86.35% (+0.29%)
50% less funds holding in top 10
Funds holding in top 10: 2 → 1 (-1)
Holders
135
Holding in Top 10
1
Calls
$1.02M
Puts
$457K
Top Buyers
| 1 | +$16M | |
| 2 | +$7.8M | |
| 3 | +$4.89M | |
| 4 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$4.79M |
| 5 |
Walleye Capital
New York
|
+$2.88M |
Top Sellers
| 1 | -$7.44M | |
| 2 | -$6.38M | |
| 3 | -$5.17M | |
| 4 |
Nuveen Asset Management
Chicago,
Illinois
|
-$4.06M |
| 5 |
IECM
Intrinsic Edge Capital Management
Chicago,
Illinois
|
-$3.38M |